Loading ...

Best Available Therapy Vs. Autologous Hematopoietic Stem Cell Transplant For MS

(

BEAT-MS

)

ITN Protocol #:

ITN077AI

Branded Name:

BEAT-MS

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Autoimmune Disease

Current Status:

Enrollment

Summary:

A Multicenter Randomized Controlled Trial of Best Available Therapy versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Biostat

ITN Clinical Trial Physician

NIAID Project Manager

NIAID Regulator Officer

Rho Scientist

Study Personnel:

Protocol Chair

Jeffrey Cohen, MDCOHENJ@ccf.org

Work: 

Protocol Chair

George Georges, MDggeorges@fredhutch.org

Work: 

(206) 667-6886

Protocol Chair

Patti Tostaptosta@immunetolerance.org

Work: 

415-353-4421

Protocol Chair

Kristin Rykerkryker@immunetolerance.org

Work: 

415-353-4405

Protocol Chair

Laura Cooney, PhDlcooney@immunetolerance.org

Work: 

734-274-1149

Protocol Chair

Noha Lim, PhDnlim@immunetolerance.org

Work: 

240-235-6151

Protocol Chair

Dawn Smilek, MD PhDdsmilek@immunetolerance.org

Work: 

415-353-4308

Protocol Chair

Julia Goldsteinjulia.goldstein@nih.gov

Work: 

240-627-3509